Negative regulation of the NLRP3 inflammasome by A20 protects against arthritis
- PMID: 25043000
- PMCID: PMC4126806
- DOI: 10.1038/nature13322
Negative regulation of the NLRP3 inflammasome by A20 protects against arthritis
Abstract
Rheumatoid arthritis is a chronic autoinflammatory disease that affects 1-2% of the world's population and is characterized by widespread joint inflammation. Interleukin-1 is an important mediator of cartilage destruction in rheumatic diseases, but our understanding of the upstream mechanisms leading to production of interleukin-1β in rheumatoid arthritis is limited by the absence of suitable mouse models of the disease in which inflammasomes contribute to pathology. Myeloid-cell-specific deletion of the rheumatoid arthritis susceptibility gene A20/Tnfaip3 in mice (A20(myel-KO) mice) triggers a spontaneous erosive polyarthritis that resembles rheumatoid arthritis in patients. Rheumatoid arthritis in A20(myel-KO) mice is not rescued by deletion of tumour necrosis factor receptor 1 (ref. 2). Here we show, however, that it crucially relies on the Nlrp3 inflammasome and interleukin-1 receptor signalling. Macrophages lacking A20 have increased basal and lipopolysaccharide-induced expression levels of the inflammasome adaptor Nlrp3 and proIL-1β. As a result, A20-deficiency in macrophages significantly enhances Nlrp3 inflammasome-mediated caspase-1 activation, pyroptosis and interleukin-1β secretion by soluble and crystalline Nlrp3 stimuli. In contrast, activation of the Nlrc4 and AIM2 inflammasomes is not altered. Importantly, increased Nlrp3 inflammasome activation contributes to the pathology of rheumatoid arthritis in vivo, because deletion of Nlrp3, caspase-1 and the interleukin-1 receptor markedly protects against rheumatoid-arthritis-associated inflammation and cartilage destruction in A20(myel-KO) mice. These results reveal A20 as a novel negative regulator of Nlrp3 inflammasome activation, and describe A20(myel-KO) mice as the first experimental model to study the role of inflammasomes in the pathology of rheumatoid arthritis.
Figures
Comment in
-
Experimental arthritis: Inflammasome-driven arthritis: a new model of RA?Nat Rev Rheumatol. 2014 Aug;10(8):445. doi: 10.1038/nrrheum.2014.116. Epub 2014 Jul 15. Nat Rev Rheumatol. 2014. PMID: 25023452 No abstract available.
Similar articles
-
Regulatory effect of zinc finger protein A20 on rheumatoid arthritis through NLRP3/Caspase-1 signaling axis mediating pyroptosis of HFLS- RA cells.Cell Mol Biol (Noisy-le-grand). 2023 Aug 31;69(8):179-184. doi: 10.14715/cmb/2023.69.8.27. Cell Mol Biol (Noisy-le-grand). 2023. PMID: 37715399
-
A20 restricts ubiquitination of pro-interleukin-1β protein complexes and suppresses NLRP3 inflammasome activity.Immunity. 2015 Jan 20;42(1):55-67. doi: 10.1016/j.immuni.2014.12.031. Immunity. 2015. PMID: 25607459 Free PMC article.
-
Involvement of the AIM2, NLRC4, and NLRP3 inflammasomes in caspase-1 activation by Listeria monocytogenes.J Clin Immunol. 2010 Sep;30(5):693-702. doi: 10.1007/s10875-010-9425-2. Epub 2010 May 20. J Clin Immunol. 2010. PMID: 20490635 Free PMC article.
-
Genetic and Epigenetic Regulation of the Innate Immune Response to Gout.Immunol Invest. 2023 Apr;52(3):364-397. doi: 10.1080/08820139.2023.2168554. Epub 2023 Feb 6. Immunol Invest. 2023. PMID: 36745138 Review.
-
The Role of NLRP3 Inflammasome in Pneumococcal Infections.Front Immunol. 2020 Dec 14;11:614801. doi: 10.3389/fimmu.2020.614801. eCollection 2020. Front Immunol. 2020. PMID: 33424869 Free PMC article. Review.
Cited by
-
Focus on the Role of NLRP3 Inflammasome in Diseases.Int J Mol Sci. 2020 Jun 13;21(12):4223. doi: 10.3390/ijms21124223. Int J Mol Sci. 2020. PMID: 32545788 Free PMC article. Review.
-
The ubiquitylation of IL-1β limits its cleavage by caspase-1 and targets it for proteasomal degradation.Nat Commun. 2021 May 11;12(1):2713. doi: 10.1038/s41467-021-22979-3. Nat Commun. 2021. PMID: 33976225 Free PMC article.
-
ZBP1 Drives IAV-Induced NLRP3 Inflammasome Activation and Lytic Cell Death, PANoptosis, Independent of the Necroptosis Executioner MLKL.Viruses. 2023 Oct 24;15(11):2141. doi: 10.3390/v15112141. Viruses. 2023. PMID: 38005819 Free PMC article.
-
Does caspase-12 suppress inflammasome activation?Nature. 2016 Jun 2;534(7605):E1-4. doi: 10.1038/nature17649. Nature. 2016. PMID: 27251234 No abstract available.
-
Endothelial Monocyte-Activating Polypeptide II Mediates Macrophage Migration in the Development of Hyperoxia-Induced Lung Disease of Prematurity.Am J Respir Cell Mol Biol. 2016 Oct;55(4):602-612. doi: 10.1165/rcmb.2016-0091OC. Am J Respir Cell Mol Biol. 2016. PMID: 27254784 Free PMC article.
References
-
- Burger D, Dayer JM, Palmer G, Gabay C. Is IL-1 a good therapeutic target in the treatment of arthritis? Best Pract Res Clin Rheumatol. 2006;20:879–896. - PubMed
-
- Matmati M, et al. A20 (TNFAIP3) deficiency in myeloid cells triggers erosive polyarthritis resembling rheumatoid arthritis. Nat Genet. 2011;43:908–912. - PubMed
-
- Lamkanfi M, Dixit VM. Inflammasomes and their roles in health and disease. Annu Rev Cell Dev Biol. 2012;28:137–161. - PubMed
-
- Wertz IE, et al. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling. Nature. 2004;430:694–699. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials